-+ 0.00%
-+ 0.00%
-+ 0.00%

Gain Therapeutics Reports First Reduction of GluSph in Parkinson’s Patients with GT-02287 in Phase 1b Trial

Reuters·12/18/2025 12:00:29

Please log in to view news